MSL
CFMS

Mackay Shields LLC’s Conformis, Inc. Common Stock CFMS Stock Holding History

Mackay Shields LLC’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,680
Closed -$401K – 1528
2019
Q2 		$401K Buy
+3,680
New +$303K ﹤0.01% 1311

Other funds holding CFMS

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mackay Shields LLC's CFMS Position: Q3 2019 in Review

Mackay Shields LLC sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2019, closing a stake of 3,680 shares — an estimated $401K sold.

Mackay Shields LLC first reported a position in CFMS in Q2 2019 and held it in 1 quarter. The position peaked at $401K in Q2 2019. 85 funds tracked by Wall St. Rank hold CFMS as of Q3 2019.

  • Mackay Shields LLC reported no remaining Conformis, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 3,680 Conformis, Inc. Common Stock shares in Q3 2019, an estimated $401K.
  • Mackay Shields LLC first reported a position in Conformis, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Mackay Shields LLC's Conformis, Inc. Common Stock position peaked at $401K in Q2 2019.
  • 85 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2019.

Based on Mackay Shields LLC's 13F filing for Q3 2019, filed 1 Nov 2019.